retatrutide benefits clinical trial retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Buy Retatrutide in the UK

Retatrutide is moving fast through clinical trials and people want to know exactly when it kicks in

On average, 1 in 2 users paused or stopped their medication within the first 4 months

Comparing Side Effects Like many medications, semaglutide and tirzepatide can cause side effects, particularly during dose increases

IEEE Trans Med Imaging

PMID: 40685589 | doi:10.1002/oby.24360 Misra S et al

Baseline Cardiovascular Assessment Before initiating therapy, clinicians should obtain a comprehensive cardiovascular history, including previous cardiac events, arrhythmias, hypertension, and family history of premature cardiovascular disease